Keywords: medigene, boosts, pipeline, munich, biotech, prods, technology

MediGene boosts R&D pipeline with Munich Biotech prods and technology

Article | 23 August 2004

Print This

MediGene AG, headquartered in Germany and with a base in San Diego, USA,has acquired the anticancer drug candidates and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in